Hejazi et al. observed a significant reduction in NK cell numbers preferentially in high-risk MDS patients and correlated their functional deficiency to low levels of granzyme B and perforin as well as the NK cells’ immaturity in MDS [156], [Figure 4]. This evidence concerns the gene GZMB and myelodysplastic syndrome.